Literature DB >> 33359669

Circ-CCS is identified as a cancer-promoting circRNA in lung cancer partly by regulating the miR-383/E2F7 axis.

Yanli Yuan1, Xiaolei Zhou1, Yan Kang2, Hongping Kuang1, Qiang Peng1, Bo Zhang1, Xinxin Liu1, Manlin Zhang3.   

Abstract

BACKGROUND: Increasing biomolecules have been found to be involved in the lung cancer development. This study will perform the function and mechanism analyses of a novel circular RNA copper chaperone for superoxide dismutase (circ-CCS) in lung cancer.
METHODS: Circ-CCS, microRNA-383 (miR-383) and E2F transcription factor 7 (E2F7) were quantified by quantitative real-time polymerase chain reaction (qRT-PCR). Cell viability was detected using Cell Counting Kit-8 (CCK-8). Clonal ability was measured by colony formation assay. Cell apoptosis was determined via flow cytometry. Cell migration and invasion were assessed by transwell assay. Detection of protein was completed using western blot. Xenograft assay was used for the functional analysis of circ-CCS in vivo. The binding between targets was proved by dual-luciferase reporter and RNA immunoprecipitation (RIP) assays. E2F7 protein level was also examined by Immunohistochemistry (IHC) analysis in human tissues.
RESULTS: Circ-CCS was upregulated in lung cancer and could predict poor prognosis. Downregulation of circ-CCS inhibited lung cancer cell growth and metastasis while promoted apoptosis in vitro, and suppressed tumorigenesis of lung cancer in vivo. Circ-CCS had sponge effect on miR-383 and the function of si-circ-CCS was achieved by upregulating miR-383. E2F7 was a target gene of miR-383 and its downregulation was responsible for the anti-cancerous role of miR-383 in lung cancer. Circ-CCS could elevate E2F7 expression via interacting with miR-383.
CONCLUSION: Circ-CCS was shown to facilitate lung cancer progression via the miR-383/E2F7 axis, exhibiting the pivotal value of circ-CCS in diagnosis and treatment of lung cancer.
Copyright © 2020 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  E2F7; Lung cancer; circ-CCS; miR-383

Year:  2020        PMID: 33359669     DOI: 10.1016/j.lfs.2020.118955

Source DB:  PubMed          Journal:  Life Sci        ISSN: 0024-3205            Impact factor:   5.037


  8 in total

1.  Mechanism of RNA circHIPK3 Involved in Resistance of Lung Cancer Cells to Gefitinib.

Authors:  Yi Zhao; Caiming Zhang; Haibo Tang; Xiaomin Wu; Qiugan Qi
Journal:  Biomed Res Int       Date:  2022-04-19       Impact factor: 3.246

2.  Development of a novel embryonic germline gene-related prognostic model of lung adenocarcinoma.

Authors:  Linjun Liu; Ke Xu; Yubai Zhou
Journal:  PeerJ       Date:  2021-10-21       Impact factor: 2.984

Review 3.  A Concise Review of MicroRNA-383: Exploring the Insights of Its Function in Tumorigenesis.

Authors:  Qian Yi; Wei Xie; Wei Sun; Weichao Sun; Yi Liao
Journal:  J Cancer       Date:  2022-01-01       Impact factor: 4.207

4.  Circular RNA UBR1 promotes the proliferation, migration, and invasion but represses apoptosis of lung cancer cells via modulating microRNA-545-5p/SSFA2 axis.

Authors:  Peng Su; Feng Mao; Jian Zhang; Hui Zhang; MingBo Wang; YanZhao Xu; ZiQiang Tian
Journal:  Bioengineered       Date:  2021-12       Impact factor: 3.269

5.  Circular RNA-UBE2D2 accelerates the proliferation and metastasis of non-small cell lung cancer cells via modulating microRNA-376a-3p/Eukaryotic Translation Initiation Factor 4γ2 axis.

Authors:  JiChun Tong; JiaWei Lu; XiaoLiang Mao; Zheng Zhu; YeMin Wang; Ming Lou; Ke Zhang
Journal:  Bioengineered       Date:  2022-03       Impact factor: 3.269

6.  CircCAMSAP1 promotes non-small cell lung cancer proliferation and inhibits cell apoptosis by sponging miR-1182 and regulating BIRC5.

Authors:  Yunfei Wang; Xiaobo Li; Huaqi Wang; Guojun Zhang
Journal:  Bioengineered       Date:  2022-02       Impact factor: 3.269

Review 7.  Circular RNA Controls Tumor Occurrence and Development via Cell Cycle Regulation.

Authors:  Fang Liu; Rongfeng Qu; Limin Yang; Guang Shi; Shuhong Hao; Chunmei Hu
Journal:  Onco Targets Ther       Date:  2022-09-15       Impact factor: 4.345

8.  Circ_0003570 Suppresses the progression of hepatocellular carcinoma through miR-182-5p/STARD13 regulatory axis.

Authors:  Xu Zhang; Wenwen Chen; Dan Guo; Yarui Li; Yan Zhao; Mudan Ren; Guifang Lu; Xinlan Lu; Shuixiang He
Journal:  Biol Proced Online       Date:  2022-10-14       Impact factor: 7.717

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.